Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia

References

• WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Trends in maternal mortality: 1990 to 2015. 2015. Geneva.
   Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005;365:785–99.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: Current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466–80.
   PubMed Web of Science ®Google Scholar
• Kalumba V, Moodley J, Naidoo T. Is the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case-control study. Cardiovasc J Afr. 2013;24:24–7.
   PubMed Web of Science ®Google Scholar
• Moodley J, Onyangunga O, Maharaj N. Hypertensive disorders in primigravid black South African women: A one-year descriptive analysis. Hypertens Pregnancy. 2016;35:1–7.
   PubMed Web of Science ®Google Scholar
• Makhanya V, Moodley J, Govender L. Eclampsia: Still a major problem in rural KwaZulu-Natal Province, South Africa. S. Afr. J Obstet Gynecol. 2016;22:13–7.
   Google Scholar
• Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31:33–46.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. Preeclampsia: The role of angiogenic factors in its pathogenesis. Physiology. 2009;24:147–58.
   PubMed Web of Science ®Google Scholar
• Redman C, Sargent I. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21:597–602.
   PubMed Web of Science ®Google Scholar
• Govender N, Naicker T, Moodley J. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia. Cardiovasc J Afr. 2013;24:174.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–76.
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor and its receptor system: Physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153:13–9.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min J-Y, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–58.
   PubMed Web of Science ®Google Scholar
• Baker PN, Krasnow J, Roberts JM, Yeo K-T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynec 1995;86:815–21.
   PubMed Web of Science ®Google Scholar
• Sharkey A, Cooper J, Balmforth J, et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest. 1996;26:1182–5.
   PubMed Web of Science ®Google Scholar
• Galazios G, Papazoglou D, Giagloglou K, et al. Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia. Int J Gynecol Obstet. 2004;85:6–11.
   PubMed Web of Science ®Google Scholar
• Roes E, Steegers E, Thomas C, et al. High levels of urinary vascular endothelial growth factor in women with severe preeclampsia. Int. J. Biol. Markers. 2003;19:72–5.
   Web of Science ®Google Scholar
• Ganju RK, Munshi N, Nair B, Liu Z-Y, Gill P, Groopman JE. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi’s sarcoma cells. JVirol. 1998;72:6131–7.
   PubMed Web of Science ®Google Scholar
• Albini A, Soldi R, Giunciuglio D, et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med. 1996;2:1371–5.
   PubMed Web of Science ®Google Scholar
• Korgaonkar SN, Feng X, Ross MD, et al. HIV-1 upregulates VEGF in podocytes. J. Am. Soc Nephrol.. 2008;19:877–83.
   PubMed Web of Science ®Google Scholar
• He JC, Husain M, Sunamoto M, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1, 2 pathways. J Clin Invest. 2004;114:643–51.
   PubMed Web of Science ®Google Scholar
• Fan X, Rai A, Kambham N, et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest. 2014;124:4941–52.
   PubMed Web of Science ®Google Scholar
• Pore N, Gupta AK, Cerniglia GJ, Maity A. HIV protease inhibitors decrease VEGF/HIF-1α expression and angiogenesis in glioblastoma cells. Neoplasia. 2006;8:889–95.
   PubMed Web of Science ®Google Scholar
• Landi B, Bezzeccheri V, Guerra B, et al. HIV infection in pregnancy and the risk of gestational hypertension and preeclampsia. World J Cardiovasc Dis. 2014;4:257–67.
   Google Scholar
• Suy A, Martínez E, Coll O, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. Aids. 2006;20:59–66.
   PubMed Web of Science ®Google Scholar
• Naicker T, Khedun SM, Moodley J, Pijnenborg R. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstetricia et Gynecologica Scandinavica. 2003;82:722–9.
   PubMed Web of Science ®Google Scholar
• Ahluwalia A, S Tarnawski A. Critical role of hypoxia sensor-HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem. 2012;19:90–7.
   Google Scholar
• Shaarawy M, Al-Sokkary F, Sheba M, et al. Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia. Int J Gynecol Obstet. 2005;88:112–7.
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:5555–63.
   PubMed Web of Science ®Google Scholar
• Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension. 2000;36:965–9.
   PubMed Web of Science ®Google Scholar
• Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: Significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest. 2002;62:343–50.
   PubMed Web of Science ®Google Scholar
• Ferrara N. VEGF: An update on biological and therapeutic aspects. Curr Opin Biotechnol. 2000;11:617–24.
   PubMed Web of Science ®Google Scholar
• Sporer B, Koedel U, Paul R, Eberle J, Arendt G, Pfister H. Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases. J. Neurol, Neurosurg & Psychiatry. 2004;75:298–300.
   PubMed Web of Science ®Google Scholar
• Lely AT, Salahuddin S, Holwerda KM, Karumanchi SA, Rana S. Circulating lymphangiogenic factors in preeclampsia. Hypertens pregnancy. 2013;32(1):42–9.
   PubMed Web of Science ®Google Scholar
• Krebs R, Jeltsch M. The lymphangiogenic growth factors VEGF-C and VEGF-D. LymphForsch 2013;17:30–7.
   Google Scholar
• Kut C, Mac Gabhann F, Popel A. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br J Cancer. 2007;97:978–85.
   PubMed Web of Science ®Google Scholar
• Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, Sibai BM. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol. 2000;183:1554–7.
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer IA, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. BJOG: An Int J Obstet Gynecol. 1997;104:223–8.
   Web of Science ®Google Scholar
• Gisterek I, Matkowski R, Lacko A, et al. Serum vascular endothelial growth factors a, C and d in human breast tumors. Pathol Oncol Res. 2010;16:337–44.
   PubMed Web of Science ®Google Scholar
• George ML, Tutton MG, Janssen F, et al. Vegf-a, vegf-c, and vegf-d in colorectal cancer progression. Neoplasia. 2001;3:420–7.
   PubMed Web of Science ®Google Scholar
• Kondo K, Kaneko T, Baba M, Konno H. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull. 2007;30:633–7.
   PubMed Web of Science ®Google Scholar